InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by David Auregan, 首席财务官. Director active across 1 company, notably THERACLION. In total, 2 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €33k. History available since 1 June 2021. The latest transaction was filed on 26 January 2024 (Acquisition). Regulator: AMF. The full history is accessible without signup.
Companies and markets linked to David Auregan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
65,417 股@ €0.50278.2% 占其流量ActionHors plateforme de négociationISIN FR00101204022024DD948364
标准退出：2024年4月25日 (T+90)
11,456 股@ €0.8021.8% 占其流量Option d'achatEuronext Growth ParisISIN FR00101204022021DD758854
2 条申报中的 2 条
About David Auregan
David Auregan is the Chief Financial Officer and Deputy CEO of Theraclion. In this role, he is responsible for the financial management of the company, including financial planning and performance analysis. His expertise in finance is essential for ensuring the profitability and sustainability of Theraclion's operations. He works closely with other executives to support the company's growth strategy.
